GHK-Cu: The Copper-Binding Tripeptide for Skin and Tissue

GHK-Cu is a small, naturally occurring peptide (glycine-histidine-lysine) bound to copper that plays a role in tissue repair, collagen production and antioxidant defense. Topical GHK-Cu has modest clinical evidence for improving the look of aging skin and supporting wound healing, while claims about hair regrowth, systemic anti-aging and injectable use rest mostly on laboratory and animal data. Injectable GHK-Cu is not FDA-approved, and its compounding status is still under federal review.

What Is GHK-Cu?

GHK was first identified in human plasma, and it is also found in saliva and urine. It binds copper (Cu²⁺) tightly, and the copper complex is considered the active form. Blood levels of GHK are reported to decline with age, which is one reason it attracted interest in skin aging research. That decline is an observation, not proof that replacing it reverses aging.

The copper itself matters. Copper is a cofactor for enzymes involved in:

• Lysyl oxidase, which cross-links collagen and elastin and gives skin its strength.
• Superoxide dismutase, an antioxidant enzyme that neutralizes reactive oxygen species.
• Tissue remodeling, including the balance of enzymes that break down and rebuild the extracellular matrix.

GHK-Cu may act partly as a copper-delivery molecule, bringing copper to tissues in a form that cells can use while limiting free copper, which can itself be harmful.

GHK-Cu Mechanism: What Lab Studies Suggest

In cell culture and animal studies, GHK-Cu has been reported to:

• Stimulate fibroblasts to produce collagen and glycosaminoglycans.
• Attract immune and repair cells to wounds.
• Reduce markers of inflammation and oxidative stress.
• Support blood-vessel formation in healing tissue.
• Encourage hair follicles toward the growth phase in animal models.

Researchers have also analyzed large gene-expression databases and reported that GHK appears to shift the activity of a large number of human genes, often in directions associated with repair. This work is frequently quoted online as "GHK-Cu resets thousands of genes." A more accurate summary is that computer-based analyses of cell-level data suggest broad effects that have not been confirmed as clinical outcomes in people.

What the Human Evidence Shows

Here is how I summarize the human data for patients:

Reasonably supported (small studies):

• Topical creams and serums containing copper peptides have shown improvements in fine lines, skin firmness and texture in small, short-term cosmetic trials. Many of these studies were industry-sponsored and not large.
• Small clinical studies have explored GHK-Cu preparations for wound healing, including in older adults, with encouraging but limited results.

Early or indirect:

• Hair density: the rationale comes largely from animal studies and small cosmetic reports. It is reasonable to try topically as part of a broader plan, but expectations should be modest.
• Systemic "anti-aging" effects: no controlled human trials show that injected GHK-Cu slows aging, improves organ function or extends healthspan.

Unknown:

• Long-term safety of repeated injections, the effects on whole-body copper and zinc balance over months to years, and interactions with conditions that affect copper metabolism.

FDA Status of GHK-Cu

This is where accuracy matters, because the rules have been changing.

• Topical cosmetic GHK-Cu is widely sold in skin and scalp products, which are regulated as cosmetics rather than drugs.
• Injectable GHK-Cu is not an FDA-approved drug. In 2023, FDA placed injectable GHK-Cu on its 503A "Category 2" list of bulk substances that raised significant safety concerns for compounding.
• On April 15, 2026, FDA removed injectable GHK-Cu, along with several other peptides, from Category 2 so that its Pharmacy Compounding Advisory Committee could review it. Injectable GHK-Cu is expected to be reviewed before February 2027.

Removal from Category 2 is not the same as approval and does not mean pharmacies are authorized to compound it. As of this writing, please check current FDA guidance. For a deeper explanation of how these lists work, see our article on compounding pharmacy regulations for peptides.

Who Should Be Cautious

Even topical copper peptides are not for everyone. Talk with a physician first if you have:

• Wilson's disease or another disorder of copper metabolism — GHK-Cu should be avoided.
• Liver disease, since the liver handles copper excretion.
• A history of contact dermatitis or metal sensitivity.
• Pregnancy or breastfeeding, where data are lacking.

Practical skin-care points also matter. Strongly acidic products and some vitamin C serums may reduce the stability of the copper complex, so many dermatology routines separate them by time of day. Retinoids and copper peptides can both irritate sensitive skin when introduced together.

How I Approach GHK-Cu in Practice

At Laeeq M.D., GHK-Cu usually comes up in conversations about skin aging, hair thinning or slow-healing tissue. My approach starts with the foundation:

1. Look for medical causes first. Thinning hair can reflect thyroid disease, iron deficiency, hormonal shifts or medications. Poor wound healing can reflect diabetes, circulation problems or nutritional gaps.
2. Prioritize proven measures. Daily sunscreen, not smoking, adequate protein and sleep do more for skin than any peptide.
3. Discuss topical options honestly, including what results are realistic and over what time frame.
4. Avoid unapproved injectable use while the regulatory status is unresolved, and monitor copper and zinc status if any systemic therapy is ever considered in the future.

If hair is your main concern, you may also find our review of zinc-thymulin for hair regrowth useful. For a side-by-side look at routes, read GHK-Cu injectable vs topical, and see the GHK-Cu library entry for a quick reference.

Sources

• Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 2018. PubMed
• U.S. Food and Drug Administration. Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks. FDA

Book a Consultation

If you are curious about GHK-Cu for skin, hair or healing, Dr. Laeeq can help you separate what is supported from what is still experimental, and look for medical causes first. Schedule a 60-minute evaluation, virtually or in person in Reston. Book a consultation when you are ready.

This article is for educational purposes and is not medical advice. Discuss any treatment with a licensed physician who knows your history.